Corticolimbic Degeneration and Treatment of Dementia

NCT00768261 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Dementia

Interventions

DRUG: Memantine (Namenda®)
DRUG: Donepezil (Aricept®)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]